$65.3 Million is the total value of MV Management XI, L.L.C.'s 3 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ROVER GROUP INC | $52,176,626 | +23.4% | 11,518,019 | 0.0% | 79.86% | +8.6% | ||
RXRX | RECURSION PHARMACEUTICALS INcl a | $13,152,626 | -13.5% | 1,971,908 | 0.0% | 20.13% | -23.9% | |
ANGI | ANGI INC | $4,308 | -3.4% | 1,898 | 0.0% | 0.01% | -12.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-02
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ROVER GROUP INC | 6 | Q1 2023 | 79.9% |
RECURSION PHARMACEUTICALS IN | 6 | Q1 2023 | 26.4% |
ANGI INC | 6 | Q1 2023 | 0.0% |
POSHMARK INC | 4 | Q3 2022 | 56.9% |
View MV Management XI, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Poshmark, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
ROVER GROUP, INC. | August 12, 2022 | 11,086,863 | 6.1% |
View MV Management XI, L.L.C.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-05-02 |
SC 13G/A | 2023-02-14 |
13F-HR | 2023-01-31 |
13F-HR | 2022-11-14 |
SC 13D/A | 2022-08-12 |
13F-HR | 2022-07-28 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-15 |
SC 13G | 2022-02-14 |
3 | 2021-10-12 |
View MV Management XI, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.